RetinaLyze

RetinaLyze is an automated eye screening algorithm

RetinaLyze is based on the vision to prevent loss of eyesight. Worldwide diabetes is an increasing problem and +300 million registered diabetics (type 1 or 2) are expected in 2020. Furthermore, +250 million unregistered diabetics are expected by 2020.

One of the most feared consequences of diabetes is retinal diabetic pathology, since this can lead to blindness. Early diagnosis is crucial – and possible with RetinaLyze.

The RetinaLyze system combines the best of the telemedicine and algorithm worlds into a service, which can help you perform screenings for DR and AMD in an easy, fast and efficient manner.

Try it for free

Optimizing sales

Are you an optometrist looking to boost your sales? Achieve your full potential and optimize your sales by providing better service to your customers using RetinaLyze.

Protecting sight

One of the most feared consequences of diabetes is retinal diabetic pathology, since this can lead to blindness. Read more about what Retinalyze does to save Eyesight.

Increase detection rate

Are you an ophthalmologist? Increase your clinical effective and save time. The RetinaLyze software finds retinal leasions in each image of the eye in only 20 seconds.

Try it for free!

We are proud of what we do and are not afraid to show it of. Try the Retinalyze software for free.

Looking for documentation?

RetinaLyze has been scientifically tested and CE-marked according to Medical Device Directive 93/42/EEC from the 14th of June 1993 and Declaration 1263 from December 2008.

Go to documentation

Some of our customers